Dopamine D 3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D 3 receptor antagonist GR103691 with typical and atypical neuroleptics

By Hurley M.J.   Stubbs C.M.   Jenner P.   Marsden C.D.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 283-293

Elsevier

Access to resources Recommend Favorite

The effect of the irreversible -opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNA

By Kawa C.   Brodsky M.   Davis T.   Franklin S.   Inturrisi C.E.   Yoburn B.C.  

European Journal of Pharmacology, Vol. 287, Iss. 2, 1995-12 ,pp. : 135-143

Elsevier

Access to resources Recommend Favorite

Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine

By Fujimura M.   Hashimoto K.   Yamagami K.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 1-10

Elsevier

Access to resources Recommend Favorite

Selective opioid receptor agonist and antagonist displacement of [ 3 H]naloxone binding in amphibian brain

By Newman L.C.   Wallace D.R.   Stevens C.W.  

European Journal of Pharmacology, Vol. 397, Iss. 2, 2000-06 ,pp. : 255-262

Elsevier

Access to resources Recommend Favorite

Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat

By Le Guen S.   Catheline G.   Besson J.-M.  

European Journal of Pharmacology, Vol. 373, Iss. 1, 1999-05 ,pp. : 1-11

Elsevier

Access to resources Recommend Favorite